About Us

Bycus Therapeutics Pvt Ltd is a R&D driven Biotechnology Company started in 2020 with the aim to develop high quality affordable solutions for healthcare and allied sectors. Biologicals are complex molecules that require cutting-edge technology to manufacture them. The promoters of the company are technopreneurs with advanced degrees like Ph.D. and domain experts with several years of experience in clone development, upstream and downstream bioprocess, quality control, and regulatory affairs. This gives Bycus a competitive edge in increasing the success rate of product development with shorter timelines. Bycus collaborates with academic and industry partners to translate discoveries and manufacture new products. Bycus is one of the fastest-growing biotech Company, with a vision to increase the affordability and standard of medical care by developing high-quality drug substances and products with the core values of integrity and a patient-first approach. The company is supported by BIRAC BIG grant. The company’s long term vision is to develop novel therapeutics with in-house research and development. Bycus therapeutics has successfully developed and transferred technology of two Biological molecules. In addition to these, Bycus is developing Bio-therapeutics for clinical indications of Gout, Diabetes and Infectious diseases. High quality Pharmaceutical enzymes are at different developmental stages.

 

We collaborate with our academic and industry partners to translate discoveries and manufacture new products. We are one of the fastest-growing biotech Company, with a vision to increase the affordability and standard of medical care by developing low-cost and high-quality drug substances and products that support the supply chain of other companies with the core values of integrity and a patient-first approach.